Generate Biomedicines Inc. is a biotechnology company pioneering the field of generative biology to create breakthrough medicines. Founded by Flagship Pioneering in 2018, the company operates at the intersection of machine learning, biological engineering, and high-throughput experimental biology. Unlike traditional drug discovery, which often relies on screening existing libraries or natural molecules, Generate Biomedicines uses its proprietary 'Generate Platform' to programmatically design de novo protein therapeutics. The Generate Platform is built upon a sophisticated computational engine that has learned the fundamental principles of protein structure and function by analyzing vast datasets of biological sequences. This allows the company to design proteins with specific, desired characteristics—such as binding affinity, stability, and potency—across various modalities, including antibodies, peptides, and enzymes. By treating drug discovery as an engineering challenge, the company aims to increase the probability of clinical success and drastically shorten development timelines. Generate Biomedicines' therapeutic pipeline spans multiple high-impact areas, including oncology, immunology, and infectious diseases. The company is led by CEO Mike Nally and a team of experts in both computational science and drug development. Through its innovative approach, Generate Biomedicines seeks to transform the pharmaceutical industry by moving from a model of serendipitous discovery to one of intentional, AI-driven design, ultimately delivering more effective treatments to patients worldwide.
Gross margin measures the amount of revenue that remains after subtracting costs directly associated with production.
The EBITDA margin is a measure of a company's operating profit desconsidering D&A costs as a percentage of its revenue.
The EBIT margin is a measure of a company's operating profit considering D&A costs as a percentage of its revenue.
The net profit margin, or simply net margin, measures how much net income or profit is generated as a percentage of revenue. It is the ratio of net profits to revenues for a company or business segment.
Many companies have a high D&A in relation to the company's operating profit (EBITDA) and although this indicator does not have an effective cash effect, it ends up influencing the accounting net income, so analyzing this relationship can help to understand when D&A has a relevant impact to the company's results.
Shows the amount spent on investments in research and development in relation to the Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
Shows the amount spent on investments in Capex in relation to Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
Indicates a comparison between investments in fixed/intangible assets and the depreciation and amortization of some company assets. It serves to let managers know that the company's assets are devaluing periodically, and whether CAPEX has followed the same pace or not.
It shows the percentage of operating cash flow that the company uses in Capex (investments in fixed and intangible assets). When your result is greater than 100%, it demonstrates that there are expenses greater than what the company produces in its operations.
It demonstrates the percentage cost of Stock-Based Compensation compared to the company's operating cash flow. In some companies, the OCF is positive because of the SBC, which can lead to an incorrect cash flow analysis.
If the company has a lot of D&A, it helps to see if most of it tends to come from fixed assets. The account can include machinery, equipment, vehicles, buildings, land, office equipment, and furnishings, among other things.
If the company has a lot of D&A, it helps to see if most of it tends to come from Goodwill, that is an intangible asset that accounts for the excess purchase price of another company.
Return on equity (ROE) is the measure of a company's net income divided by its shareholders' equity and is a gauge of a corporation's profitability and how efficiently it generates those profits.
Return on invested capital (ROIC) is a calculation used to assess a company's efficiency in allocating capital to profitable investments. The formula for calculating ROIC involves dividing Net Income by the average of invested capital.
...and much more!